The Tuesday event saw upwards of 100 WGA and SAG-AFTRA members, non-union writers and other supporters marching in the rain as they showed solidarity with the medium's east coast writers.
The faith-based political thriller has already sold more than $127 million worth of tickets at the U.S. box office, making it the sleeper hit of the summer season.
Chris Keyser added in a pointed speech that lasted over 17 minutes that when it comes to the 2023 Writers Guild of America and SAG-AFTRA negotiations, "there is no winner or loser. It’s just a deal."
Carlos Macci, 72, was sentenced to 30 months in prison for being part of a four-man crew that sold a lethal bag of fentanyl-laced heroin to Williams in 2021. According to The New York Times, the judge said that “while she sympathized with Mr. Macci’s troubles, the deadly toll of fentanyl and his decision to keep selling...
With talent unable to do press and content pipelines at risk of running dry, executives at every major streamer are quietly debating the pros and cons of holding back completed series.
The union would like performers "to share in the rewards of a successful show, without bearing any of the risk," the group that lobbies for studios says.
Caught between strict SAG-AFTRA rules and their need to work with studios to create content, Hollywood-focused social media stars are feeling the squeeze: “It's kind of an ultimatum.”
Roiland, whose exit from the Adult Swim series was announced in January in light of domestic abuse charges, had voiced the title characters since its 2013 launch.
Greta Gerwig's movie will race pass the $200 million mark at the domestic box office Tuesday, while Christopher Nolan's 'Oppenheimer' will clear $100 million.
Comic books took center stage for the first time in more than a decade as directors stepped in — sometimes awkwardly — for their stars: "I don’t have anything to say, so I don’t know why we’re here."
A clothing company says the studio used its signature backpacks in the sequel without permission and then passed off the products as a competitors' product.